Item Type | Name |
Academic Article
|
A multicenter, open-label, comparative trial of two daclizumab dosing strategies vs. no antibody induction in combination with tacrolimus, mycophenolate mofetil, and steroids for the prevention of acute rejection in simultaneous kidney-pancreas transplant recipients: interim analysis.
|
Academic Article
|
Thymoglobulin for induction or rejection therapy in pancreas allograft recipients: a single centre experience.
|
Academic Article
|
Two-dose daclizumab regimen in simultaneous kidney-pancreas transplant recipients: primary endpoint analysis of a multicenter, randomized study.
|
Academic Article
|
Retransplantation in patients with graft loss caused by polyoma virus nephropathy.
|
Academic Article
|
Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.
|
Academic Article
|
Experience with deceased donor kidney transplantation in 114 patients over age 60.
|
Academic Article
|
Banff schema for grading pancreas allograft rejection: working proposal by a multi-disciplinary international consensus panel.
|
Academic Article
|
Management of leukopenia in kidney and pancreas transplant recipients.
|
Academic Article
|
Hypertension in standard criteria deceased donors is associated with inferior outcomes following kidney transplantation.
|
Academic Article
|
Use of FK 506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection. US Multicenter FK 506 Liver Study Group.
|
Academic Article
|
Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.
|
Academic Article
|
FK 506 for rescue treatment of acute and chronic rejection in liver allograft recipients.
|
Academic Article
|
Pancreas and islet transplantation for patients with diabetes.
|
Academic Article
|
Clinical utility of histological features of polyomavirus allograft nephropathy.
|
Academic Article
|
The metabolic syndrome as a risk factor in simultaneous kidney-pancreas transplantation.
|
Academic Article
|
A randomized trial of alemtuzumab vs. anti-thymocyte globulin induction in renal and pancreas transplantation.
|
Academic Article
|
A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation.
|
Academic Article
|
Cost-effective immunosuppressive options for solid organ transplantation: a guide to lower cost for the renal transplant recipient in the USA.
|
Academic Article
|
Pancreas transplantation: lessons learned from a decade of experience at Wake Forest Baptist Medical Center.
|
Academic Article
|
Gout and transplantation: new treatment option-same old drug interaction.
|
Academic Article
|
How regenerative medicine may contribute to the achievement of an immunosuppression-free state.
|
Academic Article
|
Pancreas graft thrombosis: causes, prevention, diagnosis, and intervention.
|
Academic Article
|
Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.
|
Academic Article
|
A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation.
|
Academic Article
|
Sonography of renal transplants in dogs: the effect of acute tubular necrosis, cyclosporine nephrotoxicity, and acute rejection on resistive index and renal length.
|
Concept
|
Graft Rejection
|
Academic Article
|
Immunosuppression for pancreas transplantation with an emphasis on antibody induction strategies: review and perspective.
|
Academic Article
|
Successful unintentional ABO-incompatible renal transplantation: Blood group A1B donor into an A2B recipient.
|
Academic Article
|
Depleting antibody induction in simultaneous pancreas-kidney transplantation: a prospective single-center comparison of alemtuzumab versus rabbit anti-thymocyte globulin.
|
Academic Article
|
Semi-xenotransplantation: the regenerative medicine-based approach to immunosuppression-free transplantation and to meet the organ demand.
|
Academic Article
|
The search for the optimal antibody induction strategy in kidney transplantation: still "hazy" after all these years.
|
Academic Article
|
Kidney transplantation, bioengineering and regeneration: an originally immunology-based discipline destined to transition towards ad hoc organ manufacturing and repair.
|
Academic Article
|
Severe intellectual disability is not a contraindication to kidney transplantation in children.
|
Academic Article
|
Is prolonged cold ischemia a contraindication to using kidneys from acute kidney injury donors?
|
Academic Article
|
Delayed spontaneous hepatitis C virus elimination in a renal transplant patient following graft rejection.
|
Academic Article
|
C-peptide levels do not correlate with pancreas allograft failure: Multicenter retrospective analysis and discussion of the new OPT definition of pancreas allograft failure.
|